China (Mainland)
Diamondsupplier 
Lenvatinib,417716-92-8 CAS NO.417716-92-8
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Product Details
Keywords
- Lenvatinib
- 417716-92-8
- 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide
Quick Details
- ProName: Lenvatinib,417716-92-8
- CasNo: 417716-92-8
- Molecular Formula: C21H19ClN4O4
- Appearance: White or off-white powder
- Application: ?Lenvatinib (30 mg/kg, twice per day) ...
- Port: Shanghai
- ProductionCapacity: in stock Metric Ton/Month
- Purity: 98.0%~102.0%
- Storage: Store sealed at room temperature
- LimitNum: 1 Kilogram
- Related Substances: Any unknown impurity ≤0.1%,Total impur...
- Heavy Metal: ≤20ppm
- Valid Period: Two years
- Residual solvent: Any unknown impurity ≤0.1%,Total impur...
- Microbial limit: Total aerobic bacterial count ≤100CFU/...
Superiority
API name: Lenvatinib
Certificates: GMP, DMF
CAS No.:417716-92-8
Chemical name:
- [3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080;LENVATINIB;E7080(Lenvatinib);Lenvatinib(E7080);ER-203492-00;1-(4-(6-cChemicalbookarbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamideXEN445
Formula: C21H19ClN4O4
Structure:
Details
API name: Lenvatinib
Certificates: GMP, DMF
CAS No.:417716-92-8
Usage:
Lenvatinib (30 mg/kg, twice per day) reduces tumor growth in an H146 small cell lung cancer mouse xenograft model and induces tumor regression when administered at a dose of 100 mg/kg twice per day. Formulations containing lenvatinib have been used in the treatment of differentiated thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.
JL Pharm is profesional producer and supplier for Lenvatinib, we can supply DMF, Local GMP for this product, capacity is 1000kg/year. If you want to order produce Ipratropium bromide, please let us know.